Non-invasive Heart Test for Individuals | Cleerly
What is a Cleerly heart scan analysis? The Cleerly analysis is a thorough evaluation of the presence, amount, and type of plaque in the heart’s arteries based on a heart scan, called a coronary computed tomography angiography (CCTA).
Find a Cleerly Non-invasive Heart Scan Near You
Cleerly is creating a world without heart attacks. We are expanding Cleerly heart scans to hospitals and clinics across the country to increase access to our new standard of precision heart care. Discover your risk for heart disease. Check below for a Cleerly-enabled CCTA provider location near you.
What to Expect with a CCTA Scan - cleerlyhealth.com
2023年1月10日 · A CCTA is a heart-specific diagnostic imaging scan that helps determine if plaque buildup has narrowed the coronary arteries, the blood vessels that supply the heart, which can lead to coronary artery disease (CAD).
Personalized Analysis and Treatment of Heart Disease | Cleerly
Cleerly determines your risk of heart attack by performing a non-invasive whole heart assessment to identify, characterize, and quantify plaque buildup.
Heart Disease Technology | Cleerly
Learn how Cleerly’s AI-enabled CCTA analysis can help prevent heart attacks and improve disease treatment.
Cleerly Versus Coronary Artery Calcium Score (CACS)
2023年6月6日 · Cleerly builds on the work of past clinical trials to make CCTA analysis more precise, easily understood and personalized. Cleerly’s AI algorithms generate a 3D model of the coronary arteries, locate heart blockages, as well as identify, quantify and categorize plaque.
Ischemia Heart Scan Analysis. Reinvented. - cleerlyhealth.com
Cleerly ISCHEMIA is a first-of-its-kind, FDA-cleared heart disease evaluation that uses 37 measures of heart health to determine likelihood of coronary artery ischemia at a per-vessel level. Cleerly ISCHEMIA uses machine learning and concise reporting to aid physicians in personalizing patient treatment, including the planning of interventional ...
Cleerly's Clinical Evidence for Personalized Heart Attack Prevention
Data from six, discrete multi-center clinical trials have validated Cleerly as one of the most accurate approaches for identification, quantification and characterization of CAD. These trials show that Cleerly has superior accuracy against every current, clinical gold standard.
Medicare Administrative Contractors Approve Coverage of Cleerly …
2024年10月14日 · Several Medicare Administrative Contractors have approved Cleerly AI-QCT scans for Medicare recipients with suspected symptoms of coronary artery disease.
Cleerly Secures CPT® Category I Code for AI-QCT Advanced …
2024年10月28日 · Through its FDA-cleared solutions driven by artificial intelligence, Cleerly supports comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Cleerly’s approach is grounded in science, based on millions of images from over 40,000 patients.